Unknown

Dataset Information

A systematic review of re-induction chemotherapy for children with relapsed high-risk neuroblastoma.


ABSTRACT: BACKGROUND:Despite aggressive multimodal therapy, >50% of children with high-risk neuroblastoma (HRNB) relapse. Survival after relapse is rare, and no consensus currently exists on the most effective therapy. OBJECTIVE:To conduct a systematic review of the literature on effectiveness of re-induction chemotherapy in children with relapsed HRNB. METHODS:Database searches were performed to identify studies looking at response to 1st line chemotherapy for children >12 months at diagnosis with first relapse of HRNB. Studies not reporting separate outcomes for HRNB patients or of refractory patients only were excluded. Two independent reviewers extracted the data and assessed study quality using a modified Newcastle-Ottawa tool. RESULTS:Nine studies were identified fitting the inclusion criteria

SUBMITTER: Herd F 

PROVIDER: S-EPMC6458963 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature